Medirom Healthcare Technologies Inc.: Form 20-F for the period ended Dec 31, 2022
Filed with the SEC on May 30, 2023 and accepted by EDGAR at May 30, 2023, 20:51 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2022-01-01 to 2022-12-31 | JPY 6.95bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Selling, general and administrative | 12 months2022-01-01 to 2022-12-31 | JPY 1.81bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2022-01-01 to 2022-12-31 | JPY 97.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2022-01-01 to 2022-12-31 | JPY 9.8m | us-gaap:InterestExpense |
| Income tax | 12 months2022-01-01 to 2022-12-31 | JPY 30.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2022-01-01 to 2022-12-31 | JPY 149.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2022-01-01 to 2022-12-31 | JPY 27.23 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2022-01-01 to 2022-12-31 | JPY 30.54 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2022-01-01 to 2022-12-31 | 5,470,654 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2022-01-01 to 2022-12-31 | −JPY 685.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2022-01-01 to 2022-12-31 | JPY 120.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2022-12-31 | $4.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-12-31 | JPY 2.36bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-12-31 | JPY 6.75bn | us-gaap:Assets |
| Current liabilities | At period end2022-12-31 | JPY 3.64bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-12-31 | JPY 6.81bn | us-gaap:Liabilities |
| Long-term debt | At period end2022-12-31 | JPY 1.15bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2022-12-31 | JPY 99.2m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2022-12-31 | −JPY 59.4m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2022-12-31 | 4,882,500 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001558370-23-010611. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.